ETF Managers Group, LLC Edwards Lifesciences Corp Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, ETF Managers Group, LLC holds 6,131 shares of EW stock, worth $454,429. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,131

Previous 6,040 1.51%

Holding current value

$454,429

Previous $450,000 12.67%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$74.26 - $84.51 $6,757 - $7,690	91 Added 1.51%	6,131 $507,000
Q4 2022 Mar 23, 2023	BUY	$68.3 - $87.44 $15,026 - $19,236	220 Added 3.78%	6,040 $450,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $18,533 - $24,140	225 Added 4.02%	5,820 $481,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $234,761 - $348,124	-2,714 Reduced 32.66%	5,595 $537,000
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $14,478 - $18,224	142 Added 1.74%	8,309 $973,000
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $41,165 - $50,573	387 Added 4.97%	8,167 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $61,437 - $73,281	597 Added 8.31%	7,780 $883,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $174,051 - $217,481	2,076 Added 40.65%	7,183 $744,000
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $53,974 - $62,199	686 Added 15.52%	5,107 $423,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $28,102 - $35,762	392 Added 9.73%	4,421 $396,000
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $13,303 - $17,313	198 Added 5.17%	4,029 $316,000
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $135,161 - $180,755	2,349 Added 158.5%	3,831 $260,000
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $7,966 - $12,312	152 Added 11.43%	1,482 $291,000
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $155,517 - $178,053	-2,169 Reduced 61.99%	1,330 $309,000
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $65,920 - $80,785	-1,071 Reduced 23.44%	3,499 $760,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $133,274 - $154,004	-2,391 Reduced 34.35%	4,570 $847,000
Q1 2019 May 07, 2019	SELL	$47.89 - $64.05 $148,459 - $198,555	-3,100 Reduced 30.81%	6,961 $1.33 Million
Q4 2018 Feb 01, 2019	BUY	$46.41 - $56.94 $429,849 - $527,378	9,262 Added 1159.2%	10,061 $1.54 Million
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $234,852 - $298,216	-5,139 Reduced 86.54%	799 $139,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $220,485 - $266,452	5,194 Added 698.12%	5,938 $2.35 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $3,421 - $4,365	92 Added 14.11%	744 $101,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $3,108 - $3,623	92 Added 16.43%	652 $73,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $20,322 - $21,744	560	560 $61,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Edwards Lifesciences Corp Transaction History